 DarioHealth Corp. Nasdaq: DRIO, a leading global digital therapeutics DTx company, presented the results of two new studies at the American Diabetes Associations ADA 80th Scientific Sessions that showed sustained improvements in blood glucose levels and blood pressure among users of its digital therapeutic platform for chronic diseases. 